AzTrials
AzTrials

PainNCT06727149

The Effect of Virtual Reality on Pain, Fear and Anxiety by Children During Venipuncture

A study testing Virtual Reality Group in people with Pain and Fear, run by University of Beykent at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There are many approaches to reduce pain, fear and anxiety that may occur in children during invasive procedures. The most commonly used of these approaches is virtual reality, which is a method of distracting attention and designed with cognitive and behavioral techniques. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Pain, Fear, Anxiety
What is being tested?
Virtual Reality Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2022to 1 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The children
  • who were aged between 6-12 years
  • were healty
  • stable hemodynamics who were undergoing venipuncture
  • who were sufficient cognitive and communication abilities to rate their pain, fear, and anxiety levels,
  • were willing to participate. All participating children gave verbal consent to participate, and their families provided written consent

Who cannot join

  • Children with unstable conditions and vital signs, intubated, had visual problems or did not want to participate in the study were excluded.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Beykent University

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Using Virtual Reality on Pain, Fear and Anxiety by School-Age Children During Venipuncture: A Randomized Controlled Study

There are many approaches to reduce pain, fear and anxiety that may occur in children during invasive procedures. The most commonly used of these approaches is virtual reality, which is a method of distracting attention and designed with cognitive and behavioral techniques. This study was conducted in a randomized controlled experimental design to determine the effect of virtual reality glasses given to children during venepuncture on pain, fear and anxiety.

The research was conducted between September 2022 and May 2023 with two parallel groups in the pediatric inpatient service of a private hospital in western Turkey. The study sample consisted of children aged 6-12 years and the sample was randomization, the control group (n=30) and the virtual training group (30) constituted a total of 60. The data of the study were obtained from Child Information Form, Wong-Baker Faces Pain Rating Scale, State-Trait Anxiety Inventory for children. The data were analyzed using SPSS 25 program.

Read the detailed description

This randomized controlled clinical trial (RCT) was conducted between September 2022 and May 2023 with two parallel groups in the pediatric inpatient service of a private hospital in western Turkey.

In order to determine the number of patients constituting the research sample, a similar study in the relevant literature was taken as an example and the power analysis G*Power 3.1 software was used. In this study, in order to reach a power level of 95% at a 0.5 effect size and 5% error level, the sample size was calculated as 56, with 28 participants in each group. Considering the high power of the test and the losses in the study, a total of 60 people were reached, 30 in each group.The study sample consisted of children aged 6-12 years with stable hemodynamics who were undergoing venipuncture, had sufficient cognitive and communication abilities to rate their pain, fear, and anxiety levels, and were willing to participate. This group was selected because children of that age are the most cooperative. All participating children gave verbal consent to participate, and their families provided written consent. Children with unstable conditions and vital signs, intubated, had visual problems or did not want to participate in the study were excluded.

Children meeting the sampling criteria were randomly allocated to one of the two groups: the VR group and the control group. First, group numbers were written on uniform pieces of paper as 30 VR 30 control, and the papers were placed into closed box. Participants were asked to pick one card among the 60. They were assigned to the group according to their card. Thus, each group had 30 children in each group and 60 children in the study.

The research's outcomes were pain levels assessed with the Wong-Baker Faces Pain Rating Scale (WBS), fear levels assessed with the Children's Fear Scale (CFS), anxiety levels assessed with the State-Trait Anxiety Inventory for children (STAI-CH). WBS and CFS were scored separately by the researcher, the child and the parent, and STAI-CH was scored by the child alone within five minutes before and immediately after the procedure. All ratings were done blindly to ensure that the observers did not influence each other's scores.

The researchers created the child information form and included nine questions about the children's age, sex, parents' age, education level, economic level, and type of family.

Procedure One researcher (İ.A.) provided information about the study to the children and their parents in the patient rooms. Children who met the inclusion criteria were included in the study and informed consent forms were obtained from the child and parent. Participants were randomly assigned to the groups. The child information form was filled out. The WBS and CFS were obtained from the child and parent by another researcher (G.A.), and the STAI-CH was obtained from the child. Researcher İ.A. scored the WBS and CFS blindly to the child and parent's responses. The children were told that intravenous access would be established and that they would be asked to assess their fear and anxiety with the CFS and STAI-CH immediately before the procedure. The instructions regarding the scales were read to the children. The children scored on paper. Then, the child's parent was asked to score the CFS according to the child's fear. The child and parent did not see each other's scores. Researcher İ.A. scored the CFS. Researcher G.A. was not blinded to the children's and parents' scores.

All children were allowed to have their families with them during the vascular access procedure. The vascular access procedure was performed by the same person in all groups (H.K.). The researcher introduced the materials to the child. After the child gave permission by asking, "Which arm can I open the vascular access in?", the researcher performed the vascular access procedure. If the procedure was unsuccessful, the child was asked for permission to use the other arm. If the child did not want the vascular access immediately, a period of time was waited. When the child was ready, the researcher performed the procedure again. The children in the VR group were informed about the virtual reality glasses and told that they could remove the glasses at any time if they felt uncomfortable during the procedure (Researcher İ.A.). Before the vascular access procedure began, the children were given VR glasses (Oculus Quest 2) and were allowed to watch the three-dimensional video until the procedure was completed. No intervention other than the standard procedure was performed on the children in the control group during the vascular access procedure. In both groups, the child, parent, and researcher (İ.A.) scored the WBS and CFS blindly to each other immediately after the procedure. The child was also asked to score the STAI-CH.

Data analysis The data obtained in the study were analyzed using SPSS (Statistical Package for Social Sciences) for Windows 22.0 program. Descriptive statistical methods were used in the evaluation of the data as number, percentage, mean, standard deviation. Differences between the rates of categorical variables in independent groups were analyzed with Chi-Square and Fisher exact tests. T-test was used to compare quantitative continuous data between two independent groups. Dependent groups t-test was used to compare within-group measurements. Relationships between the dependent variables of the study were tested with Pearson correlation and regression analysis. In this study, the reliability of the Wong-Baker Facial Expressions Rating Scale was found to be high as Cronbach's Alpha=0.872, the reliability of the Child Fear Scale as Cronbach's Alpha=0.869, and the reliability of the State Anxiety Scale for Children as Cronbach's Alpha=0.885. Pain; Fear was assessed by the child, parent and researcher and the agreement between the assessments was found to be high (Kappa (κ) =0.789, p=0.000). Fear was assessed by the child, parent and researcher and the agreement between the assessments was found to be high (Kappa (κ) =0.816, p=0.000).

Conditions
Pain, Fear, Anxiety
Being tested
Control Group, Virtual Reality Group
Keywords
pain management, pain in children, fear in children, anxiety, virtual reality
Medical subject headings
Pain, Anxiety Disorders, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control GroupOther

    No intervention was performed to reduce pain, fear and anxiety in the control group

  • Virtual Reality GroupOther

    Also called Experimental

    The children in the VR group were informed about the virtual reality glasses and told that they could remove the glasses at any time if they felt uncomfortable during the procedure

Study groups in NCT06727149
Study groupRoleWhat they receive
Control Group (Standard Procedure)ExperimentalNot described
Receives: Other: Control Group
Virtual Reality GroupExperimentalNot described
Receives: Other: Virtual Reality Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain severity

    The children and parents informed about Wong BakerFaces Pain

    Measured: 8 month

Secondary outcomes (2)
  1. Fear levels

    The children and parents informed about Children Fears Scale

    Measured: 8 month

  2. Anxiety levels

    The children and parents informed about STAI

    Measured: 8 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2024
  2. Study start1 Sep 2022
  3. Primary completion1 Nov 2022
  4. Study completion1 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06727149
Sponsor's protocol ID
02082022
Status last verified
Dec 2024
First submitted
6 Dec 2024
Last updated
10 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kizil H, Karaca E, Aksucu G, Azap I. The Effect of Using Virtual Reality on Pain, Fear, and Anxiety in School-Age Children During Venipuncture: A Randomized Controlled Study. Healthcare (Basel). 2026 Sep 1;14(17):2770. doi: 10.3390/healthcare14172770.

    PubMed 42736926

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Group in people with Pain and Fear, run by University of Beykent at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain severity (time frame: 8 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06727149, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06727149 | AzTrials